| |
FOR: CARDIOCOMM SOLUTIONS, INC.
TSX VENTURE SYMBOL: EKG
TORONTO, ONTARIO - August 2, 2013. CardioComm
Solutions, Inc. ("CardioComm Solutions"
or the "Company") (TSX VENTURE:EKG), a global
medical provider of ECG acquisition and management
software solutions, today announced that it has
issued an aggregate of 377,129 common shares of
the Company in settlement of services provided, as
previously described in the Company's press
release dated July 12, 2013.
A total of 350,000 common shares were issued at a
deemed price of $0.15 per share, for a total value
of $52,500, to an arm's length service provider as
compensation for services to be described in a
subsequent press release. An additional 27,129
common shares were issued to Mr. Simi Grosman, a
member of the Company's board of directors, for
services rendered to the Company in the months of
April, May and June of 2013 pursuant to a services
agreement dated January 11, 2013. The shares were
issued at a 5% premium to the closing price of the
Company's shares at the end of each month and
represent a scheduled payment under the services
agreement that will occur once per fiscal quarter.
The total value of the shares issued is $4,500.
The shares issued are subject to a four month hold
period which will expire on December 1, 2013.
About CardioComm Solutions
CardioComm Solutions' patented and proprietary
technology is used in products for recording,
viewing, analyzing and storing electrocardiograms
(ECGs) for diagnosis and management of cardiac
patients. Products are sold worldwide
through a combination of an external distribution
network and a North American-based sales
team. The Company has earned the ISO 13485
certification, is HPB approved, HIPAA compliant,
and has received FDA market clearance for its
software devices. CardioComm Solutions, Inc.
is headquartered in Toronto, Canada with offices
in Victoria, B.C.
For Further Information On Cardiocomm Solutions
Please Contact: Etienne Grima, Chief Executive
Officer
1-877-977-9425
egrima@cardiocommsolutions.com
www.cardiocommsolutions.com
Forward-looking statements
This release may contain
certain forward-looking
statements with respect to
the financial condition,
results of operations and business of
CardioComm Solutions and certain of the plans and
objectives of CardioComm Solutions with respect to
these items. By their nature, forward-looking
statements involve risk and uncertainty because
they relate to events and depend on circumstances
that will occur in the future and there are many
factors that could cause actual results and
developments to differ materially from those
expressed or implied by these forward-looking
statements.
Neither TSX Venture Exchange nor its Regulation
Services Provider (as that term is defined in
policies of the TSX Venture Exchange) accepts
responsibility for the adequacy or accuracy of
this release.
|
|
